Acute myopia and angle-closure glaucoma induced by topiramate

Neurology

Volumn 61, Issue 9, 2003, Pages 1306-

  Boentert, Matthias ^a   Aretz, Herbert ^b   Ludemann, Peter ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETAZOLAMIDE; CARBONATE DEHYDRATASE; LATANOPROST; TOPIRAMATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLOSED ANGLE GLAUCOMA; DRUG WITHDRAWAL; EYE REFRACTION; FEMALE; FOCAL EPILEPSY; HUMAN; INTRAOCULAR PRESSURE; MYOPIA; PRIORITY JOURNAL;

EID: 0242578755     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000091425.43083.C1     Document Type: Article

References (7)

1. Zweifler RM, McKinley B, Duval D. Topiramate-induced myopia. Headache 2002;42:85-86.
2. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol 2001;119:1210-1211.
3. Chen TC, Chao CW, Sorkin JA. Topiramate induced myopic shift and angle closure glaucoma. Br J Ophthalmol 2003;87:648-649.
4. Medeiros FA, Zhang XY, Bernd AS, Weinreb RN. Angle-closure glaucoma associated with ciliary body detachment in patients using topiramate. Arch Ophthalmol 2003;121:282-285.
5. NDA 20-505/S-002, NDA 20-844/S-010. Approved labeling text dated 08/28/01. Available at: www.fda.gov/medwatch/SAFETY/2001/topamax-.label_changes.pdf. Accessed June 29, 2003.
6. Ortho-McNeil Pharmaceutical. TOPAMAX product information. Revised version, May 2002. Raritan, NJ: OMP Division, Ortho-McNeil Pharmaceutical, 2002.
7. Postel EA, Assalian A, Epstein DL. Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusions. Am J Ophthalmol 1996;122:110-112.